dc.contributor.author | Gleeson, M | |
dc.contributor.author | Peckitt, C | |
dc.contributor.author | To, YM | |
dc.contributor.author | Edwards, L | |
dc.contributor.author | Chau, I | |
dc.contributor.author | Johnson, P | |
dc.contributor.author | Ardeshna, KM | |
dc.contributor.author | Wotherspoon, A | |
dc.contributor.author | Attygalle, A | |
dc.contributor.author | Begum, R | |
dc.contributor.author | Chua, S | |
dc.contributor.author | Zerizer, I | |
dc.contributor.author | Hawkes, EA | |
dc.contributor.author | Macheta, MP | |
dc.contributor.author | Collins, GP | |
dc.contributor.author | Radford, JA | |
dc.contributor.author | Forbes, A | |
dc.contributor.author | Hart, A | |
dc.contributor.author | Montoto, S | |
dc.contributor.author | McKay, P | |
dc.contributor.author | Benstead, K | |
dc.contributor.author | Morley, N | |
dc.contributor.author | Kalakonda, N | |
dc.contributor.author | Hasan, Y | |
dc.contributor.author | Turner, D | |
dc.contributor.author | Cunningham, D | |
dc.date.accessioned | 2018-02-19T16:31:44Z | |
dc.date.issued | 2017-06 | |
dc.identifier.citation | Hematological Oncology, 2017, 35 pp. 75 - 76 | |
dc.identifier.issn | 0278-0232 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/1327 | |
dc.identifier.doi | 10.1002/hon.2437_63 | |
dc.format.extent | 75 - 76 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | Wiley | |
dc.title | CHOP VERSUS GEM-P IN THE FIRST-LINE TREATMENT OF T-CELL LYMPHOMA (PTCL): INITIAL RESULTS OF THE UK NRCI PHASE II RANDOMISED CHEMO-T TRIAL | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1002/hon.2437_63 | |
rioxxterms.licenseref.startdate | 2017-06 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Hematological Oncology | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 35 | |
pubs.embargo.terms | Not known | |
dc.contributor.icrauthor | Marsden, | en |